Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 214

    1.

    Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome.

    Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES.

    Diabetes Care. 2003 Jul;26(7):2119-25.PMID: 12832323 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

    Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A.

    Diabetes. 1999 Sep;48(9):1856-62.PMID: 10480619 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

    Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.

    Metabolism. 2003 Feb;52(2):173-80.PMID: 12601628 [PubMed - indexed for MEDLINE]Related articles

    4.

    Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.

    Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR.

    J Clin Endocrinol Metab. 2007 Mar;92(3):969-75. Epub 2006 Dec 27.PMID: 17192290 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes.

    Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, Katsilambros N, Horton ES, Veves A.

    Metabolism. 2004 Feb;53(2):222-7.PMID: 14767875 [PubMed - indexed for MEDLINE]Related articles

    6.

    Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease.

    Shechter M, Beigel R, Freimark D, Matetzky S, Feinberg MS.

    Am J Cardiol. 2006 Jun 1;97(11):1650-3. Epub 2006 Apr 7.PMID: 16728231 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    9.

    Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.

    Caballero AE, Bousquet-Santos K, Robles-Osorio L, Montagnani V, Soodini G, Porramatikul S, Hamdy O, Nobrega AC, Horton ES.

    Diabetes Care. 2008 Mar;31(3):576-82. Epub 2007 Dec 14.PMID: 18083792 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects.

    Davison K, Coates AM, Buckley JD, Howe PR.

    Int J Obes (Lond). 2008 Aug;32(8):1289-96. Epub 2008 May 27.PMID: 18504447 [PubMed - indexed for MEDLINE]Related articles

    11.

    Improvement of insulin resistance and early atherosclerosis in patients after gastric banding.

    Hanusch-Enserer U, Cauza E, Spak M, Endler G, Dunky A, Tura A, Wagner O, Rosen HR, Pacini G, Prager R.

    Obes Res. 2004 Feb;12(2):284-91.PMID: 14981221 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.

    de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E.

    Diabetes Care. 2006 May;29(5):1083-9.PMID: 16644641 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.

    Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A.

    J Clin Endocrinol Metab. 2004 Feb;89(2):740-7.PMID: 14764790 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.

    Beer S, Feihl F, Ruiz J, Juhan-Vague I, Aillaud MF, Wetzel SG, Liaudet L, Gaillard RC, Waeber B.

    Vasc Health Risk Manag. 2008;4(6):1449-58.PMID: 19337558 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.

    Meyer MF, Lieps D, Schatz H, Pfohl M.

    Microvasc Res. 2008 May;76(1):61-5. Epub 2008 Mar 20.PMID: 18448131 [PubMed - indexed for MEDLINE]Related articles

    16.

    Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.

    Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D, Campia U, Turriziani M, Fusco A, Cocciolillo G, Lauro R.

    Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):349-56. Epub 2007 Nov 1.PMID: 17935958 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relation of cumulative weight burden to vascular endothelial dysfunction in obesity.

    Arkin JM, Alsdorf R, Bigornia S, Palmisano J, Beal R, Istfan N, Hess D, Apovian CM, Gokce N.

    Am J Cardiol. 2008 Jan 1;101(1):98-101.PMID: 18157973 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X.

    Jadhav ST, Ferrell WR, Petrie JR, Scherbakova O, Greer IA, Cobbe SM, Sattar N.

    Am J Cardiol. 2006 Jun 15;97(12):1727-31. Epub 2006 Apr 21.PMID: 16765122 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.

    de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD.

    Circulation. 2004 Jun 1;109(21):2529-35. Epub 2004 May 10.PMID: 15136505 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.

    Ketel IJ, Stehouwer CD, Serné EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R, Lambalk CB.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3365-72. Epub 2008 Jul 1.PMID: 18593766 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...